As differential levels of ADAMTSL2 in blood samples predict the onset and degree of liver fibrosis [6], efforts should be made to investigate ADAMTSL2 as blood biomarker of cardiac fibrosis, and possibly also other ADAMTSL molecules (Fig. 3). Here, ADAMTSL2 is linked to Hepatic fibrosis.